Opportunity Information: Apply for CDC RFA TP12 12010301SUPP15
Apply for CDC RFA TP12 12010301SUPP15
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) Cooperative Agreements/ PHEP Supplemental for Ebola Virus Disease Active Monitoring and Direct Active Monitoring Activities" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.074 Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) Aligned Cooperative Agreements.
- This funding opportunity was created on Dec 31, 2014 and posted on Dec 18, 2014.
- Applicants must submit their applications by Jan 20, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,726,415.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $379,487.00 in funding.
- The number of recipients for this funding is limited to 62 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Only recipients that are currently funded under FOA TP12 1201
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a CDC supplemental cooperative agreement tied to the existing Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) cooperative agreements. Its main goal is to help the 62 currently funded PHEP jurisdictions build out and run systems for active monitoring (AM) and direct active monitoring (DAM) of travelers who may have been exposed to Ebola virus disease. The emphasis is on making sure people with a credible exposure risk are followed in a structured, public health-led way so that any illness is recognized immediately after symptoms begin, followed by rapid isolation and medical evaluation to protect both the individual and the broader public.
The work supported by the award centers on two related approaches. Active monitoring (AM) means the state or local public health authority takes responsibility for regular, proactive communication with potentially exposed individuals. In practice, that includes daily check-ins to assess whether symptoms have appeared and whether the person has a fever, rather than putting the burden entirely on the traveler to self-monitor and only call if they start feeling sick. Direct active monitoring (DAM) is a more intensive version of the same concept, where the public health authority performs monitoring through direct observation. The underlying public health purpose of both approaches is early detection: if someone with epidemiologic risk factors develops symptoms, the system is designed to catch that change as soon as possible so the person can be promptly evaluated, safely transported if needed, and isolated to reduce the chance of further spread.
The opportunity frames AM and DAM as critical public health actions because they create a dependable routine for symptom checks while also ensuring there is an operational response system ready to act when symptoms are reported or observed. That response capacity is a key part of preparedness: monitoring is not just collecting information, but linking monitoring results to rapid decision-making about clinical assessment, appropriate medical care, and protective measures. By supporting jurisdictions in setting up and implementing these monitoring and response processes, the program aims to strengthen readiness for Ebola-related risks associated with travel and to improve overall public protection.
Administratively, this is a discretionary funding opportunity using a cooperative agreement mechanism, meaning CDC would have an ongoing programmatic role rather than acting only as a pass-through funder. The funding opportunity number is CDC RFA TP12-12010301SUPP15, and it is specifically limited to applicants that already receive funding under FOA TP12-1201. In other words, this is a supplemental award for existing PHEP recipients rather than a competition open to new jurisdictions or organizations.
The announcement projected 62 awards, aligning with the 62 PHEP jurisdictions referenced in the description. The estimated total funding amount was $4,726,415, with individual award amounts ranging from a floor of $25,000 to a ceiling of $379,487. There was no cost sharing or matching requirement. The posting date was December 18, 2014, with an original and final closing date of January 20, 2015, and the opportunity was archived on February 19, 2015. The issuing agency was the Centers for Disease Control and Prevention.
For applicants needing help obtaining the full announcement, the listed contact was the CDC Procurement and Grants Office, Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a CDC supplemental cooperative agreement that supports the build-out and operation of systems for active monitoring (AM) and direct active monitoring (DAM) of travelers who may have been exposed to Ebola virus disease.
What is the main goal of the award?
The main goal is to help the 62 currently funded PHEP jurisdictions establish and run structured, public health-led monitoring and response systems so that illness is recognized immediately after symptoms begin, followed by rapid isolation and medical evaluation to protect both the individual and the broader public.
Which existing programs is this supplement tied to?
The supplement is tied to the existing Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) cooperative agreements.
Who is eligible to apply?
Eligibility is limited to applicants that already receive funding under FOA TP12-1201. This is a supplemental award for existing PHEP recipients and is not open to new jurisdictions or organizations.
How many jurisdictions are expected to be funded?
The opportunity projected 62 awards, aligning with the 62 PHEP jurisdictions referenced in the announcement.
What does "active monitoring (AM)" mean in this opportunity?
Active monitoring (AM) means the state or local public health authority takes responsibility for regular, proactive communication with potentially exposed individuals. In practice, this includes daily check-ins to assess symptoms and whether the person has a fever, rather than relying solely on the traveler to self-monitor and only call if they feel sick.
What does "direct active monitoring (DAM)" mean?
Direct active monitoring (DAM) is a more intensive form of monitoring in which the public health authority performs monitoring through direct observation.
Why are AM and DAM emphasized as critical public health actions?
AM and DAM are emphasized because they create a dependable routine for symptom checks and ensure there is an operational response system ready to act when symptoms are reported or observed. The purpose is early detection and rapid action to reduce the chance of further spread.
What happens if a monitored person develops symptoms?
The monitoring system is designed so that if someone with epidemiologic risk factors develops symptoms, that change is detected as soon as possible and the person can be promptly evaluated, safely transported if needed, and isolated to reduce the chance of further spread.
Is this award only about collecting symptom information?
No. The opportunity describes monitoring as linking monitoring results to rapid decision-making about clinical assessment, appropriate medical care, and protective measures. The emphasis includes having response capacity ready to act based on monitoring findings.
What funding mechanism is being used?
This is a discretionary funding opportunity using a cooperative agreement mechanism.
What does a cooperative agreement imply about CDC's role?
A cooperative agreement implies CDC would have an ongoing programmatic role rather than acting only as a pass-through funder.
What is the funding opportunity number?
The funding opportunity number is CDC RFA TP12-12010301SUPP15.
What is the estimated total funding amount?
The estimated total funding amount was $4,726,415.
What is the minimum and maximum award amount per recipient?
Individual award amounts ranged from a floor of $25,000 to a ceiling of $379,487.
Is cost sharing or matching required?
No. The announcement stated there was no cost sharing or matching requirement.
When was the opportunity posted and when did it close?
The posting date was December 18, 2014. The original and final closing date was January 20, 2015.
Is this opportunity still open?
No. The opportunity was archived on February 19, 2015.
Which federal agency issued this opportunity?
The issuing agency was the Centers for Disease Control and Prevention (CDC).
Who should be contacted to obtain the full announcement or technical information?
Applicants needing help obtaining the full announcement were directed to the CDC Procurement and Grants Office, Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: USAID/Uganda Literacy Achievement and Retention Activity
Previous opportunity: Enabling Quantification of Uncertainty in Physical Systems (EQUiPS)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA TP12 12010301SUPP15
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA TP12 12010301SUPP15) also looked into and applied for these:
| Funding Opportunity |
|---|
| Epidemiologic Study of Interstitial Cystitis Apply for RFA DP 15 010 Funding Number: RFA DP 15 010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| EBOLA HEALTHCARE PREPAREDNESS AND RESPONSE FOR SELECT CITIES WITH ENHANCED AIRPORT ENTRANCE SCREENINGS FROM AFFECTED COUNTRIES IN WEST AFRICA Apply for EP U3R 15 001 Funding Number: EP U3R 15 001 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $1,000,000 |
| Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Services and Outcomes Apply for RFA DD 15 003 Funding Number: RFA DD 15 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Alcohol Biosensors (STTR)(R41/R42) Apply for RFA AA 15 007 Funding Number: RFA AA 15 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Biosensors (SBIR)(R43/R44) Apply for RFA AA 15 008 Funding Number: RFA AA 15 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Grants for Preventing Violence and Violence Related Injury (R01) Apply for RFA CE 15 001 Funding Number: RFA CE 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Nuclear Organization and Function Interdisciplinary Consortium (NOFIC)(U54) Apply for RFA RM 14 030 Funding Number: RFA RM 14 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Health Research on Modifiable Risk Factors for Spina Bifida Apply for RFA DD 15 001 Funding Number: RFA DD 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Comparison and Validation of Screening Tools For Substance Use Among Pregnant Women Apply for RFA DP 15 003 Funding Number: RFA DP 15 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Evaluation of a Stepped Care Approach for Perinatal Depression Treatment in Obstetrics and GynecologyClinics Apply for RFA DP 15 005 Funding Number: RFA DP 15 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Cooperative Agreements to Support Comprehensive Medical Care for Thalassemia Apply for HRSA 15 079 Funding Number: HRSA 15 079 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Hemophilia Program Coordinating Center Apply for HRSA 15 087 Funding Number: HRSA 15 087 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Effectiveness of Teen Pregnancy Prevention Programs Designed Specifically for Young Males Apply for RFA DP 15 007 Funding Number: RFA DP 15 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Nurse Faculty Loan Program (NFLP) Apply for HRSA 15 049 Funding Number: HRSA 15 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving Surveillance and Prevention of Epilepsy Burden in US Communities Apply for RFA DP 15 009 Funding Number: RFA DP 15 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Population Based Birth Defects Surveillance and Utilization of Surveillance Data by Public Health Programs Apply for CDC RFA DD15 1508 Funding Number: CDC RFA DD15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Sentinel Enhanced Dengue Surveillance System (SEDSS) Sites to Evaluate the Epidemiology and Prevention of Dengue and other Acute Febrile Illnesses in Puerto Rico Apply for RFA CK 15 002 Funding Number: RFA CK 15 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Detection and Characterization of Emerging Vector Borne Zoonotic Apply for RFA CK 15 001 Funding Number: RFA CK 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Capacity Building to Prevent, Detect, and Respond to Emerging Infectious Disease Threats and Strengthen Global Health Security in Uganda Apply for RFA CK 15 003 Funding Number: RFA CK 15 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation Apply for RFA TS 13 0010501SUPP15 Funding Number: RFA TS 13 0010501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $360,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA TP12 12010301SUPP15", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.